Truth in Media: Feds Says Cannabis Is Not Medicine While Holding Patents on Cannabis as Medicine [View all]

[nationalize the fed]

Federal Pot Patent #6,630,507 October 7, 2003
uspto.gov/6630507
Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC)

Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia.

Federal Pot Patent #6,410,588 June 25, 2002
uspto.gov/6410588
Assignee: The Mathilda and Terence Kennedy Institute of Rheumatology (London, GB)
Yissum Research and Development Company of the Hebrew University of Jerusalem (Jerulasem, IL)

The application relates to the identification that cannabinoids, such as cannabidiol can be used to treat inflammatory diseases. Cannabinoids for use in treating inflammatory diseases, methods of treating inflammatory diseases and cannabinoids in combination with pharmaceutically acceptable carriers are claimed.